Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Genscript Biotech ( ($HK:1548) ) just unveiled an announcement. Genscript Biotech Corporation held its Annual General Meeting on May 29, 2025, ...

Cathie Wood’s ARK ETFs have made their daily trades for Thursday, 29 May 2025, with a notable increase in shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and a continued sell-off of Adaptive ...

Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Melbourne biotech PolyActiva says it hopes to be the next Cochlear by selling its eye drug dispensing system to millions ...

Sam Altman, best known as the CEO of OpenAI, has steadily built a large and diverse investment portfolio that spans ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

The grant, which would have benefitted the Birmingham Biotechnology Hub, led by Southern Research, has been cancelled. The ...

The Greater Baltimore Committee’s latest investment summit captured the optimism of an ecosystem bolstered by big private employers, startups, universities, government and beyond.